Correlation of ROS1 Immunohistochemistry With ROS1 Fusion Status Determined by Fluorescence In Situ Hybridization

Huang R. S. P., Smith D., Le C. H., Liu W., Ordinario E., Manohar C., ...More

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, vol.144, no.6, pp.735-741, 2020 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 144 Issue: 6
  • Publication Date: 2020
  • Doi Number: 10.5858/arpa.2019-0085-oa
  • Journal Name: ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, CINAHL, EMBASE, MEDLINE, Public Affairs Index
  • Page Numbers: pp.735-741
  • Istanbul University Affiliated: Yes

Abstract

Context.-The ability to determine ROS1 status has become mandatory for patients with lung adenocarcinoma, as many global authorities have approved crizotinib for patients with ROS1-positive lung adenocarcinoma.